The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) is organising a multi-stakeholder round table discussion on the theme of the future of rare diseases in Europe: Revision of the European Orphan & Paediatric Regulation and impact for the Nordic Rare Disease Community in the context of review of the European legislation on paediatric medicines (EC 1901/2006) and Orphan Medicinal Products (OMPs) (EC 141/2000).
The fully online event will take place on September 7th from 12.00 – 13.30 CET.
The event features a keynote address by Terkel Anderson, President of the EURORDIS Board, and a distinguished panel of speakers from Nordic countries who will discuss how to best ensure that the regulatory environment is both conducive to innovation and contributes to Nordic rare disease patients’ access to innovative therapies.
More information and registration here: https://zoom.us/webinar/register/WN_GzGuP0JlTXykqmlT8_JQ5Q
